ATP-gated ion channel P2X receptors are expressed on the surface of most immune cells and can trigger multiple cellular responses, such as membrane permeabilization, cytokine production, and cell proliferation or apoptosis. Despite broad distribution and pleiotropic activities, signaling pathways downstream of these ionotropic receptors are still poorly understood. Here, we describe intracellular signaling events in Jurkat cells treated with millimolar concentrations of extracellular ATP. Within minutes, ATP treatment resulted in the phosphorylation and activation of p56 lck kinase, extracellular signalregulated kinase (ERK), and c-Jun N-terminal kinase but not p38 kinase. These effects were wholly dependent upon the presence of extracellular Ca 2؉ ions in the culture medium. Nevertheless, calmodulin antagonist calmidazolium and CaM kinase inhibitor KN-93 both had no effect on the activation of p56 lck and ERK, whereas a pretreatment of Jurkat cells with MAP kinase kinase inhibitor P098059 was able to abrogate phosphorylation of ERK. Extracellular ATP and other nucleotides act through specific cell surface receptors and can regulate a variety of cellular responses in many cell types and tissues (1-7). Among them are such different phenomena as platelet aggregation, smooth muscle contractility, excitatory transmitter function, mitogenic stimulation, or induction of cell death (reviewed in Refs. 1 and 8). The biological effects of extracellular nucleotides are mediated via stimulation of two primary classes of purinergic receptors, P1 and P2. The P1 receptors are responsive to adenosine, whereas the P2 receptors respond to a variety of nucleotides, including ATP (7, 9). The P2 receptors are subdivided in two mechanistically distinct subclasses, the metabotropic G protein-coupled P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11-13) and the ionotropic ligand-gated channel P2X receptors (P2X1-7) (9 -12). Activation of the P2Y receptors generally induces downstream signaling through the G protein-coupled activation of phospholipase C, followed by Ca 2ϩ mobilization from intracellular stores (13, 14) . The P2Y11 also activates adenylyl cyclase, whereas the P2Y12 inhibits it (15). The seven subunits of the ionotrophic ATP-gated P2X receptor family comprise a different subclass, ranging from 379 to 595 amino acids in length and regulating the intracellular level of Ca 2ϩ by ligand-stimulated increase in cell membrane permeability for extracellular Ca 2ϩ ions (7, 16, 17) . The P2X7 receptor is a 595-amino acid polypeptide and has a structure similar to that of other P2X receptors with two membrane-spanning domains, a large extracellular loop, and intracellular N-and C-terminal domains (18, 19) . In contrast to other P2X receptors, the P2X7 C-terminal intracellular chain is about 200 amino acids longer (20, 21) . The P2X7 has a pharmacological profile similar to the receptor previously designated as P2Z, with prominent expression in many immune cells (lymphocytes, monocytes/macrophages, dendritic, mesangial, and microglial cells) (7, 20) , and requires millimolar levels of ATP in the presence of divalent cations to achieve activation (22, 23) . Although each of the P2X receptors is capable of forming heteromers with other family members in a specific pattern (24), the P2X7 cannot heteropolymerize with any other P2X subunit (25). Activation of the P2X7 receptor results in the formation of a nonselective cationic channel with low affinity for ATP and increased permeability to Ca 2ϩ , intracellular depolarization, and equilibration of sodium and potassium gradients (18, 26) . In addition, the P2X7 receptor may also induce a nonselective pore with uncharacterized structure able to pass molecules up to 900 Da, sharing this ability, albeit to a lesser degree, with other P2X family members (7, 27) . Continuous activation of the receptor and the formation of a large transmembrane pore can cause perturbations in ion homeostasis and finally result in cell death (20, 28) . Depending on the cell background, stimulation of the P2X7 receptor by ATP triggers diverse biological responses, such as post-translational process-
lck
-deficient isogenic T cell line JCaM1, suggesting a critical role for p56 lck kinase in downstream signaling. Regarding the biological significance of the ATP-induced signaling events we show that although extracellular ATP was able to stimulate proliferation of both Jurkat and JCaM1 cells, an increase in interleukin-2 transcription was observed only in Jurkat cells. The nucleotide selectivity and pharmacological profile data supported the evidence that the ATP-induced effects in Jurkat cells were mediated through the P2X7 receptor. Taken together, these results demonstrate the ability of extracellular ATP to activate multiple downstream signaling events in a human T-lymphoblastoid cell line.
Extracellular ATP and other nucleotides act through specific cell surface receptors and can regulate a variety of cellular responses in many cell types and tissues (1-7). Among them are such different phenomena as platelet aggregation, smooth muscle contractility, excitatory transmitter function, mitogenic stimulation, or induction of cell death (reviewed in Refs. 1 and 8) . The biological effects of extracellular nucleotides are mediated via stimulation of two primary classes of purinergic receptors, P1 and P2. The P1 receptors are responsive to adenosine, whereas the P2 receptors respond to a variety of nucleotides, including ATP (7, 9) . The P2 receptors are subdivided in two mechanistically distinct subclasses, the metabotropic G protein-coupled P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11-13) and the ionotropic ligand-gated channel P2X receptors (P2X1-7) (9 -12) . Activation of the P2Y receptors generally induces downstream signaling through the G protein-coupled activation of phospholipase C, followed by Ca 2ϩ mobilization from intracellular stores (13, 14) . The P2Y11 also activates adenylyl cyclase, whereas the P2Y12 inhibits it (15) . The seven subunits of the ionotrophic ATP-gated P2X receptor family comprise a different subclass, ranging from 379 to 595 amino acids in length and regulating the intracellular level of Ca 2ϩ by ligand-stimulated increase in cell membrane permeability for extracellular Ca 2ϩ ions (7, 16, 17) . The P2X7 receptor is a 595-amino acid polypeptide and has a structure similar to that of other P2X receptors with two membrane-spanning domains, a large extracellular loop, and intracellular N-and C-terminal domains (18, 19) . In contrast to other P2X receptors, the P2X7 C-terminal intracellular chain is about 200 amino acids longer (20, 21) . The P2X7 has a pharmacological profile similar to the receptor previously designated as P2Z, with prominent expression in many immune cells (lymphocytes, monocytes/macrophages, dendritic, mesangial, and microglial cells) (7, 20) , and requires millimolar levels of ATP in the presence of divalent cations to achieve activation (22, 23) . Although each of the P2X receptors is capable of forming heteromers with other family members in a specific pattern (24) , the P2X7 cannot heteropolymerize with any other P2X subunit (25) . Activation of the P2X7 receptor results in the formation of a nonselective cationic channel with low affinity for ATP and increased permeability to Ca 2ϩ , intracellular depolarization, and equilibration of sodium and potassium gradients (18, 26) . In addition, the P2X7 receptor may also induce a nonselective pore with uncharacterized structure able to pass molecules up to 900 Da, sharing this ability, albeit to a lesser degree, with other P2X family members (7, 27) . Continuous activation of the receptor and the formation of a large transmembrane pore can cause perturbations in ion homeostasis and finally result in cell death (20, 28) . Depending on the cell background, stimulation of the P2X7 receptor by ATP triggers diverse biological responses, such as post-translational process-ing of precursors of IL-1␤ 1 and IL-18 in human monocytes (29, 30) , altered cytokine production in mice lacking this receptor (31) , stimulation of JNK activity and induction of apoptosis in murine macrophages (26) , inhibition of osteoclastic resorption (32) , and activation of transcription factor NF-B (33) and nuclear factor of activated T cells (NFAT) (34) in microglial cell lines. Despite the accumulating evidence for an important function of the P2X7 receptor in many cellular systems, intracellular signaling events underlying the biological processes upon the P2X7 stimulation in immune cells are still obscure.
The activation of protein-tyrosine kinases constitutes one of the initial steps for the induction of signaling cascades, which ultimately results in the activation of T cell effector function (35) . p56 lck kinase is a lymphoid-specific cytoplasmic proteintyrosine kinase with a molecular size of about 56 kDa that mediates initial events in TCR/CD3 signaling, such as phosphorylation of the TCR complex within amino acid sequences known as immunoreceptor-based tyrosine activation motifs (35, 36) , which serve as docking sites for Src homology domain 2-containing molecules, predominantly Zap-70 and Syk (35, 37) , and activation of mitogen-activated protein (MAP) kinases (38) . The MAP kinase cascade represents another key signaling pathway, critical for the linking membrane receptors to cytoplasmic and nuclear effectors. Extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 are serine/threonine kinases, which constitute major components of this inducible signaling pathway and regulate many intracellular events, including cell proliferation and differentiation (39, 40) . Upon activation, the MAP kinases phosphorylate various cytoplasmic effector proteins and are translocated to the nucleus, where they participate in the regulation of the gene expression by acting on transcription factors (39, 41) .
The present study focuses on intracellular signaling events in Jurkat cells treated with millimolar concentrations of extracellular ATP. We show here that ATP induces phosphorylation and activation of p56 lck kinase, ERK, and JNK. These events are prerequisite for the subsequent increase in the expression of c-Jun and c-Fos proteins and activation of transcription factor AP-1. On the contrary, DNA binding activity of p50 and p65 (RelA) subunits of NF-B transcription factor was reduced. The observed effects were wholly dependent on the extracellular Ca 2ϩ influx and, in regard to the pharmacological profile and expression pattern, are likely to be exclusively mediated by the P2X7 receptor. Finally, the experiments aimed to characterize the biological significance of the signaling pathway involved showed that ATP was able to stimulate proliferation of Jurkat cells and to induce an increase in transcription of IL-2. Thus, the data presented in this study demonstrate the ability of extracellular ATP to elicit diverse cellular responses in a human T-lymphoblastoid cell line.
MATERIALS AND METHODS
Reagents and Antibodies-All of the reagents used were of analytical grade. ATP was obtained from Roche Molecular Biochemicals. PD098059, an inhibitor of MEK (42) ; suramine, an antagonist of the P2 receptors (43) ; calmidazolium, an antagonist of calmodulin (44); KN-93, an inhibitor of Ca 2ϩ /calmodulin-dependent protein kinase II (CaM kinase) (44) ; and KN-92, an inactive analog of KN-93, were purchased from Calbiochem-Novabiochem (La Jolla, CA). 1[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62) and oxidized ATP (oATP), both antagonists of the P2X7 receptor (7, 45, 46 ); 3-O-(4Ј-benzoyl)-benzoyl-benzoyl-ATP (Bz-ATP), an agonist of the P2X7 receptor (7); and UTP, GTP, adenosine, and calcium ionophore A23187 were purchased from Sigma. Anti-Tyr(P) antibodies (horseradish peroxidase-conjugated (RC20H) and biotinylated (RC20B)) were obtained from Transduction Laboratories (Lexington, KY). Antibodies against ERK (C-16), pERK (E-4), pJNK (G-7), pp38 (D-8), Lck (3A5), NF-B p50 (C-19), p65 (A), c-Rel (N-466), cyclin D (R-124), Fos (4), Jun (N), Myc (C-19), P2X7 (L-20) were purchased from Santa Cruz (Santa Cruz, CA); anti-pLck (pY505) and anti-pSrc (pY416) were purchased from BioSource Int. (Camarillo, CA).
Cell Culture and Stimulation Conditions-Human T-lymphoblastoid cell line Jurkat, its p56 lck -deficient derivative variant JCaM1, and stable transfectants of JCaM1 expressing p56 lck cDNA in pBP1 vector or mock pBP1 vector (last three lines were kindly provided by Dr. D. Straus, University of Chicago) (36) were maintained in RPMI 1640, supplemented with 10% fetal calf serum, 100 units/ml penicillin, and 100 mg/ml streptomycin. Transfectants were maintained in the presence of 0.5 mg/ml of G418 and 0.5 mg/ml hygromycin. Before treatment the cells were washed twice with Dulbecco's phosphate-buffered saline and incubated in RPMI 1640 without fetal calf serum at 37°C for 3 h.
The cells (5 ϫ 10 6 ) were activated by ATP (final concentration, 3 mM) for different time intervals at 37°C. Activation was interrupted by adding ice-cold phosphate-buffered saline with 10 mM EDTA and 100 mM sodium vanadate. Then the cells were pelleted and stored at Ϫ80°C until electrophoresis.
Immunoprecipitation, Western Blotting, and Kinase Assay-The cell pellets were lysed in 1% Nonidet P-40 cell extraction buffer (20 mM Tris-HCl buffer, pH 8.0, with 15 mM NaCl, 1% Nonidet P-40, 2 mM EDTA, 1 mg/ml pepstatin A, 1 mg/ml leupeptin, 10 mM phenylmethylsulfonyl fluoride, and 100 mM sodium vanadate). The detergent-insoluble material was removed by centrifugation for 15 min at 13.000 and 4°C. Protein concentrations were determined using a bovine serum albumin protein assay kit (Bio-Rad), and 50 g of proteins were analyzed by electrophoresis in 10% SDS-PAGE. For immunoprecipitation, 500 g of proteins were incubated overnight at 4°C with 5 g/ml of RC20B or anti-Lck antibodies. Immunocomplexes were captured on protein A-agarose (Bio-Rad) or streptavidin-agarose (Pierce), respectively, with gentle mixing for 1 h at 4°C and analyzed in 10% SDS-PAGE. Visualization of specific proteins was carried out by an ECL method using ECL Western blotting detection reagents (Amersham Biosciences) according to the manufacturer's recommendations.
For kinase assay, immunocomplexes were washed with 25 mM HEPES (pH 7.4), 2 mM MnCl 2 , 10 mM MgCl 2 , 1 mM Na 3 VO 4 , and incubated in 60 l of 5 mM HEPES, 2 mM MnCl 2 , 10 mM MgCl 2 , 1 mM Na 3 VO 4 , 10 Ci of [␥- 32 P]ATP (3000 Ci/mmol; Amersham Biosciences), 10 M ATP, and 1 g of GST-TCR fusion protein (p56 lck substrate, generously provided by Dr. D. Straus) for 15 min at 37°C. The reaction was stopped by adding 20 l of 4ϫ sample buffer. The samples were boiled for 5 min, and the proteins were resolved in 10% SDS-PAGE. The phosphotyrosine-containing proteins were detected by autoradiography.
RNA Extraction and RT-PCR-Cellular RNA was extracted from the cells using TRIZOL reagent (Invitrogen) according to the manufacturer's instructions. A 5-g aliquot of total cellular RNA was reverse transcribed using random hexanucleotides as primers and a Superscript II preamplification kit (Invitrogen). cDNA was amplified in 50 l of PCR reaction mixture, containing 250 M of each dNTP, 200 nM primers, 5 l of 10-fold PCR buffer with 1.5 mM MgCl 2 and 1 unit of Taq DNA polymerase (Amplitaq; Applied Biosciences, Warrington, UK). The primers used were: human P2X7 receptor (GenBank TM accession number Y09561): sense, 5Ј-TCCGAGAAACAGGCGATAA-3Ј, and antisense, 5Ј-ACTCGCACTTCTTCCTGTA-3Ј; human IL-2 (GenBank TM accession number NM 000586): sense, 5Ј-TACAACTGGAGCATTTAC-TGC-3Ј, and antisense, 5Ј-TTGACAAAAGGTAATCCATCT-3Ј; human ␤-actin (GenBank TM accession number NM 001101): sense, 5Ј-GTGG-GGCGCCCCAGGCACCA-3Ј, and antisense, 5Ј-CTCCTTAATGTCACG-CACGATTTC-3Ј. All of the primers were purchased from TIB Molbiol (Berlin, Germany). The samples were amplified in a DNA Thermocycler (Eppendorf, Hamburg, Germany) for 35 cycles. Each cycle consisted of denaturation at 94°C for 30 s, annealing at 60°C for 1 min, and extension at 72°C for 1 min. Aliquots of PCR products were electrophoresed on 1.5% agarose gel and visualized by ethidium bromide staining. To evaluate mRNA expression semi-quantitatively, in addition to the PCR product from 35 cycles, 15 l of the PCR product from the 25 cycles and the 30 cycles was run simultaneously. ␤-Actin message was used to normalize the cDNA amount to be used. A mock PCR (without cDNA) was included to exclude contamination in all experiments. 
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Electromobility Shift Assay (EMSA)-Nuclear extracts from 2 ϫ 10 6 cells were prepared according to the method of Schreiber et al. (47) . EMSA was performed by incubating 4 mg of nuclear extract with 16 fmol of 32 P end-labeled double-stranded NF-B oligonucleotides from the HIV long terminal repeat, 5Ј-TTGTAACAAGGGACTTTCCGCTG-GGGACTTTCCAGGGAGGCGTGG-3Ј or with AP-1 oligonucleotides, 5Ј-CGCTTGATGACTCAGCCGGAA-3Ј and 3Ј-GCGAACTACTGAGTCGG-CCTT-5Ј (underlined regions are consensus NF-B or AP-1 sites). A binding reaction was performed in 20 l of reaction buffer (20 mM Tris-Cl, pH 7.9, 20% glycerol, 50 mM KCl, 1 mM dithiothreitol, and 2.5 mM MgCl 2 ) containing 4 g of nuclear proteins, 2 g of poly(dI-dC), and 1 ng of end-labeled DNA (10,000 -30,000) at room temperature, loaded on 4% polyacrylamide gel, and run in 0.5ϫ TBE buffer (89 mM Tris, 89 mM boric acid, pH 8.3). The gels were dried in a gel dryer and exposed to an x-ray film. A double-stranded mutated oligonucleotides were used to prove the specificity of binding of NF-B or AP-1 to the DNA. The specificity was also proven by competition with the unlabeled ("cold") oligonucleotides. To characterize NF-B⅐DNA and AP-1⅐DNA complexes, supershifting assay was performed using anti-p65, anti-p50, anti-c-Rel antibodies, and anti-c-Fos/c-Jun antibodies, respectively. For cell survival assays, Jurkat cells were cultured at 1 ϫ 10 5 cells/ml in triplicate at 37°C for 1-3 days in RPMI medium in the presence of 3 mM ATP. The cells were harvested, and cell viability was determined by fluorescence-activated cell sorter analysis with 5 g/ml of propidium iodide. The percentage of apoptotic cells was evaluated by an ApoTarget annexin V-fluorescein isothiocyanate apoptosis kit (BioSourse Int.) according to the manufacturer's protocol and analyzed on a FACScalibur (Becton Dickinson, San Jose, CA) using CELLQuest software.
Intracellular Ca 2ϩ Measurement-The cells were preincubated with 2 M of Fura-2 (Molecular Probes, Eugene, OR) for 30 min at 37°C, and Ca 2ϩ influx was measured in Hitachi F-2500 spectrophotometer (Hitachi, Tokyo, Japan) using 350/385 excitation filters. After recording of background for 20 s, the cells were stimulated with 3 mM ATP, and the concentration of Ca 2ϩ was calculated using the equation of Grinkievich et al. (48) .
Changes in Plasma Membrane Permeability-ATP-dependent increases in plasma membrane permeability were measured with the extracellular fluorescent tracers Lucifer yellow (Molecular Probes) and ethidium bromide (Sigma), as described earlier (25) . For Lucifer yellow uptake, the cells were incubated for 15 min at 37°C in buffer (125 mM NaCl, 5 mM KCl, 1 mM MgSO 4 , 1 mM Na 2 HPO 4 , 5.5 mM glucose, 5 mM NaHCO 3 , 20 mM HEPES, pH 7.4) containing 250 M sulfinpyrazone and 1 mg/ml Lucifer yellow and stimulated with 3 mM of ATP. After several washings to remove the extracellular dye, the cells were analyzed with an inverted fluorescence microscope (Nikon Diaphot 300, Tokyo, Japan) using a 40ϫ objective and a fluorescein filter. For ethidium bromide uptake, the cells were incubated in a fluorometer cuvette (37°C) at a concentration of 10 6 cells/ml in the presence of 20 M ethidium bromide and challenged with various ATP concentrations. The fluorescence changes were monitored at the wavelength 360 -580 nm.
Statistical Analysis-All of the experiments were performed in at least three independent assays, which yielded highly comparable results. The data are presented as the mean values Ϯ S.D. as indicated in the figure legends. The Mann-Whitney-U test was used to determine the level of statistical significance.
RESULTS

Extracellular ATP Induces Activation of p56
lck Kinase-Protein-tyrosine kinases are critically involved in signaling pathways that regulate cell growth, differentiation, and activation. The activation of downstream signaling events, including the Ras/Raf/MAP kinase pathway, the phosphatidylinositol pathway, and the phosphatidylinositol 3-kinase pathway, was shown to be dependent upon protein-tyrosine kinase functions (39, 49) . Thus, we studied first the ability of purinoreceptors to mediate intracellular signaling in response to extracellular ATP by incubating Jurkat cells with various concentrations of ATP for different time intervals and evaluating the phosphorylation of protein-tyrosine kinases. In the experiments illustrated in Fig. 1 , Jurkat cells were treated with 3 mM ATP. Immunoprecipitation and probing with anti-Tyr(P) antibodies at the indicated time points showed that a number of proteins were phosphorylated upon the exposure of the cells to extracellular ATP. These included 40 -42-, 56-, 70-, and 80 -85-kDa proteins (Fig. 1A) . Such a phosphorylation pattern was already detectable within the first 5 min of ATP administration, reaching its maximum at 15 min and returning to a near basal level within 30 min. Reportedly, T cell activation often involves the recruitment of p56 lck kinase, which is essential for T cell development and function (36) . Reprobing of the blots with antip56 lck -specific antibodies allowed us to identify among the phosphorylated proteins p56 lck kinase (Fig. 1B) . Other kinases of the Src family, such as c-Src, Lyn, and Fyn as well as Syk and ZAP-70, which are often recruited for signal transduction in T cells (50) , were not involved (data not shown). To confirm the phosphorylation of p56 lck kinase upon ATP administration, immunoblotting of anti-p56 lck precipitates with anti-Tyr(P) antibodies was carried out (Fig. 1C) . As shown in the picture, ATP induced transient phosphorylation of p56 lck within 5-15 min of treatment, and this effect significantly declined within 15-30 min. For loading control, the stripped membranes were reprobed with anti-p56 lck antibodies (Fig. 1D) . Thus, the kinetic experiments revealed that ATP stimulated the rapid and transient phosphorylation of p56 lck kinase. According to several reports, the activity of p56 lck is regulated by phosphorylation at two tyrosine residues, Tyr 394 and Tyr 505 (51) (52) (53) lck (52, 53) . We immunoprecipitated p56 lck and probed the membrane with phosphospecific antibodies to Tyr 416 of human c-Src (which corresponds to Tyr 394 in p56 lck ) (53) and with antibodies to Tyr 505 -Lck to detect which tyrosine residues are phosphorylated in p56 lck kinase after exposure to extracellular ATP. As shown in Fig. 2A (53) , a kinase assay was performed to determine whether ATP also affects p56 lck kinase catalytic activity. We incubated p56 lck -precipitates with [␥-32 P]ATP and an exogenous substrate consisting of the cytosolic domain of the -chain of the TCR fused to GST (38) . As it is shown in Fig. 2B , ATP activates the kinase activity of p56 (26) . Several studies reported an important role for p56 lck kinase in the activation of the MAP kinase pathway (38, 57) . Based on these findings, our next goal was to determine whether ATP is able to induce the activation of ERK and JNK MAP kinases in Jurkat cells. The cells were incubated with ATP, and the activation of the MAP kinases ERK and JNK was evaluated by employment of phosphospecific antibodies directed against the C termini of ERK1 and ERK2 (both phosphorylated at Tyr 204 ) (55) and JNK1 and JNK2 (phosphorylated at Thr 183 and Tyr 185 , respectively) (40) . Kinetic experiments revealed that ATP induced rapid and transient phosphorylation and activation of ERK1 (p44) and ERK2 (p42), as well as JNK1 (p54) and JNK2 (p52) in a time-dependent manner (Fig. 3) . Phosphorylation of both kinases was already detectable within 5 min of ATP administration, reaching its maximum after 15 min and returning to near basal levels within 3 h. On the other hand, the phosphorylation state of p38 kinase was not affected, remaining at the same level throughout the time course of the experiment (Fig.  3) . For loading control, the membranes were stripped and reprobed with anti-ERK, anti-JNK, or anti-p38 antibodies, respectively. The activation of MAP kinases by ATP required a sustained increase in the intracellular Ca 2ϩ concentration and Ca 2ϩ influx across the plasma membrane, because it was inhibited by the depletion of extracellular Ca 2ϩ ions in extracellular medium (data not shown).
To investigate the mechanism of activation of ERK, we examined the effects of a specific inhibitor of MAP kinase kinase (MEK), PD098059 (42) . The ERK activation cascade is believed to proceed through sequential activation of three protein kinases, MAP kinase kinase kinase, MEK, and MAP kinase (42) . Thus, we used PD098059 to study whether it can block phosphorylation of ERK in response to the ATP treatment. The cells were incubated with 50 M of PD098058 for 90 min and then stimulated with ATP. Untreated cells were used as a control. As shown in Fig. 4A , PD098059 was able to inhibit the phosphorylation of ERK (top panel). The second panel shows the control of loading. At the same time, the phosphorylation pattern of p56 lck was not altered. The lysates from PD098059-treated and ATP-activated cells were precipitated with antip56 lck antibodies, and phosphorylation of p56 lck at Tyr 394 was evaluated by SDS-PAGE using anti-pY416(c-Src) specific antibodies. As shown in Fig. 4A (third panel) , PD098059 did not affect ATP-mediated phosphorylation of p56 lck kinase. For control of loading, these membranes after stripping were probed with anti-p56 lck antibodies (Fig. 4A, bottom lck . Calcium ionophore A23187 and an inactive analog of KN-93, KN-92, were used as controls. As shown in Fig. 4B (left panel) , ATP alone induced a rapid activation of ERK1/2 after 5 min of treatment, with a peak within 15 min. In agreement with the previous report (44), A23187 also was able to trigger activation of ERK. However, calmidazolium at a concentration of 5 M was able to abrogate A23187-induced but not ATP-induced activation of ERK1/2 ( Fig 4B,  upper left panel) . The second panel shows control of loading. Then we immunoprecipitated p56 lck and probed the membrane with phosphospecific antibodies to detect the activation of p56 lck . As shown in Fig. 4B , ATP induced the phosphorylation and activation of the kinase in a time-dependent manner both in the absence and presence of calmidazolium, clearly indicating that ATP-mediated activation of p56 lck is not dependent on calmodulin. The lower membrane was probed with anti-p56 lck antibodies to prove the control of loading. The experiments with CaM kinase inhibitor KN-93 revealed that although ATP preserved the ability to activate both p56 lck and ERK1/2 (Fig.  4B, right panels) , this effect was slightly diminished when compared with its inactive analog, KN-92. Lower membranes show the control of loading. Notably, KN-93 was able to completely inhibit the activation of ERK and p56 lck in response to calcium ionophore A23187, whereas KN-92 had no effect. The difference between action of KN-93 and KN-92 on Jurkat cells after stimulation with ATP deserves additional exploration and may reflect the partial involvement of CaM kinase to the observed activation of p56 lck and ERK1/2 in response to ATP, although this speculation requires further proof. Nevertheless, the ability of ATP to induce the activation of ERK1/2 and p56 lck kinase even in the presence of CaM kinase inhibitor KN-93 strongly supports the idea that such an effect is elicited mainly via a CaM kinase-independent mechanism.
Taken together, these results confirm the ability of extracellular ATP to trigger the phosphorylation and activation of ERK1/2 and JNK1/2 but not p38 kinase and show the contribution of MEK to the activation of ERK. In addition, such activation of p56 lck kinase and ERK1/2 appears not to be dependent on calmodulin and only partially, if at all, dependent on CaM kinase.
Activation of p56 lck and MAP Kinases by ATP Is Mediated through the P2X7 Receptors-To identify both the specificity of the response and the identity of the receptors involved in ATPinduced activation of p56 lck and MAP kinases in Jurkat cells, a panel of purinoreceptors was tested for their ability to activate these kinases. Each purinoreceptor subtype is defined by its relative response to different purinergic ligands (7, 9) . In our preliminary experiments, we did not observe the activation of p56 lck and MAP kinases in response to the treatment with adenosine, ADP, AMP, GTP, or UTP (data not shown). Adenosine has been demonstrated to be a selective agonist of P1 receptors (13) . UTP serves as a high potency agonist for human P2Y2 and P2Y4 receptors, whereas at P2Y1 and P2Y11 it is inactive (7). ADP activates P2Y12 and P2Y13 and was reported to be equipotent or even more potent as ATP for P2Y1, whereas for P2Y11 ATP is more potent than ADP (7, 12, 13) . UDP selectively activates P2Y6 (7, 58) . The unique, naturally occurring agonist of P2X receptors is ATP (7, 13, 14) .
Adenosine and UTP showed no ability to induce phosphorylation of ERK and p56 lck kinase in Jurkat cells at a concentration of 100 M (Fig. 5A ) or higher (data not shown). These results indicated that the P1 receptor as well as the P2Y2 and P2Y4 were not involved in the observed ATP-mediated effects. Next, RT-PCR was performed to test mRNA expression in the Jurkat cells of five mammalian P2Y receptors (P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11). We were not able to detect a message 
of the P2X family were utilized. The expression of three receptors of the P2X family, P2X1, P2X5 (data not shown), and P2X7 (Fig. 5B, left panel) , was identified at mRNA level. Because the fact that only rather high concentrations of ATP (1 mM and above) were required to induce the typical phosphorylation pattern supports the involvement of the P2X7 receptor (22, 23, 26) , our major interest was focused on the P2X7 subunit. Therefore, we performed Western blotting experiments with antibodies to the P2X7 receptor to confirm the presence of the P2X7 protein in the cell lysates (Fig.  5B, right panel) .
As a next step, a number of various agonists and antagonists were used to assess the involvement of each P2X receptor in the ATP-mediated signaling. Reportedly, suramine antagonizes the effect of ATP on the P2X purinoreceptors and was shown at concentration of 30 M to block ATP-induced calcium influx (7, 59) . Pretreatment of Jurkat cells with suramine at a concentration 30 M for 30 min prior to stimulation with ATP abolished the phosphorylation of MAP and p56 lck kinases (Fig. 5A , first and third panels). Treatment of Jurkat cells with 100 M Bz-ATP, which is believed to be a more potent agonist for the P2X7 receptors than ATP (7, 26) , resulted in the increase of phosphorylation of ERK as well as p56 lck kinase at levels similar to those induced by ATP (Fig. 5A) . Further, we employed KN-62, an isoquinoline derivative and inhibitor of CaM kinase II, which is widely used as a most potent and selective antagonist of the P2X7 receptor (45) . In addition, another effective inhibitor of the P2X7 receptor, oATP, was used (46) , although data are available indicating multiple P2X receptor targets for this agent (26) . Pretreatment of Jurkat cells with KN-62 (1 M) for 5 min or with oATP (300 M) for 30 min prior to stimulation with ATP was able to abrogate the activation of the MAP and p56 lck kinases (Fig. 5A, first and third panels) . For loading control, we detected ERK or p56 lck kinase on the same membranes after stripping (Fig. 5A, second and fourth panels) .
It has been repeatedly reported that signal transduction through the P2X7 receptor is associated with Ca 2ϩ influx across the cellular membrane (5, 32) and may also open a nonselective pore capable of allowing uptake of low molecular mass hydrophilic solutes (up to 900 Da), such as Lucifer yellow and ethidium bromide (7, 27) . Therefore, we investigated whether these effects take place in ATP-stimulated Jurkat cells. ATP at various concentrations (1-3 mM) was not able to induce the uptake of Lucifer yellow (Fig. 5C ) or ethidium bromide (data not shown) by Jurkat cells. Human macrophages were used as a positive control. Notwithstanding, as shown in Fig. 5D , both ATP and Bz-ATP were able to induce transmemto the P2X7 receptor was performed (left panel). The amplified products from this reaction were analyzed by 1.5% agarose gel electrophoresis. A mock PCR (ϪDNA) was included as a negative control. Expression of the P2X7 receptor was analyzed in Jurkat cell lysates using specific anti-P2X7 antibodies (right panel). The position of the P2X7 receptor is indicated on the right. C, membrane permeabilization was analyzed in Jurkat cells by fluorescence microscopy (right panels). The cells were incubated in the absence (control) or presence of 3 mM ATP for 15 min in a buffer containing 1 mg/ml Lucifer yellow, washed, and examined under phase contrast (left panels) or fluorescent light using a fluorescent filter (right panels). (Fig. 6A) , although this speculation requires further proof. The expression of another transcription factor, c-Myc, which served as a control, remained at the same level (Fig. 6A, bottom panel) .
Finally, nuclear extracts from activated cells were analyzed for AP-1-DNA binding activity using oligonucleotides carrying a consensus for an AP-1-binding site. ATP induced an enhancement in the AP-1-DNA binding activity that was already detectable within the first 30 min and continued to increase, reaching a peak at the third hour of activation (Fig. 6B) . To determine the composition of ATP-induced AP-1 complex, nuclear extracts from ATP-treated Jurkat cells were incubated with different antibodies and then assayed for AP-1 by EMSA. The ability of antibodies against c-Fos and c-Jun to supershift the band to the higher molecular mass position, as shown in Fig. 6C , suggested that these two proteins are the part of activated AP-1 complex. Irrelevant antibodies (anti-cyclin D) had no effect on the mobility of AP-1. Specificity of the AP-1⅐DNA complexes was demonstrated by competition assays where the addition of cold AP-1 oligonucleotides inhibited the formation of AP-1⅐DNA complex, whereas mutated AP-1-consensus motif oligonucleotides failed to show any binding. Taken together, these results indicate that ATP induces the increase in the expression of c-Jun/c-Fos proteins and enhances AP-1⅐DNA binding activity in Jurkat cells.
Extracellular ATP Down-regulates NF-B Transcription Factor-The NF-B family of transcription factors controls the expression of numerous genes involved in T cell function and can be activated in response to a broad variety of stimuli. Many agents that activate NF-B also activate AP-1 transcription factor (57, 64) . Therefore, as a next step, we wanted to study the effect of ATP on NF-B activity. Jurkat cells were treated for different time intervals with ATP, and the nuclear extracts were examined for NF-B DNA binding activity by EMSA. Fig.  7A shows that ATP transiently inhibits NF-B binding activity within 1-2 h of treatment. To prove that the retarded band visualized by EMSA is NF-B, we incubated nuclear extracts with antibodies against p50 (NF-BI), p65 (Rel A), or c-Rel and then performed EMSA. Antibodies against p50 and p65 of NF-B supershifted the band to the higher molecular mass position (Fig. 7B) , suggesting that ATP-activated complex consists of these two subunits. Either anti-c-Rel or irrelevant antibodies (anti-cyclin D) had no effect on the mobility of NF-B. Specificity of binding was proved using EMSA with cold NF-B oligonucleotides. Incubation of nuclear extracts with unlabeled oligonucleotides completely blocked NF-B⅐DNA complex formation (Fig. 7B) , and mutated NF-B consensus motif oligonucleotides failed to bind NF-B. Therefore, extracellular ATP is able to down-regulate the NF-B transcription factor in Jurkat cells. (Fig. 8, B and C) . Absence of p56 lck in JCaM1 and JCaM/vectorϩ cells did not affect ATPmediated Ca 2ϩ influx as shown in Fig. 8D , whereas KN-62, an antagonist of the P2X7 receptor, was able to completely abrogate this effect in all cell lines used (data not shown). In addition, ATP was not able to trigger uptake of Lucifer yellow or ethidium bromide by JCaM1, JCaM1/Lckϩ, or JCaM/vectorϩ cells (data not shown).
Effects of Extracellular ATP on p56 lck -deficient JCaM1
Further, the JCaM1 cell lines described above were utilized to study the importance of p56 lck for the ATP-induced intracellular events. In striking contrast, stimulation with ATP of JCaM1 and JCaM/vectorϩ cells did not result in the phosphorylation of ERK and JNK, increased expression of c-Jun and c-Fos proteins (Fig. 9) , and AP-1 activation but induced Ca 2ϩ influx across the plasma membrane (data not shown). However, JCaM1/Lckϩ cells displayed a phosphorylation pattern resembling that of Jurkat cells, namely the activation of MAP kinases (Fig. 9 ) and increased expression of c-Jun and c-Fos (data not shown). Thus, these results strongly suggest that ATP-mediated effects in JCaM1 cells, such as ERK and JNK phosphorylation, increased expression of c-Jun and c-Fos proteins, and activation of AP-1 but not Ca 2ϩ influx are dependent on the proper expression and function of p56 lck kinase.
Extracellular ATP Stimulates Proliferation of Jurkat Cells and Increases Transcription of IL-2-
To understand the biological significance of the described intracellular events in response to ATP, we evaluated the consequences of activation of the P2X7 by ATP on Jurkat cell survival and growth. Given the well documented ability of ATP to induce cell death via both apoptotic or necrotic mechanisms in many cell types (28, (31) (32) (33) (34) , we wanted to test whether such effect could also be observed in Jurkat and JCaM1 cells. The cells were cultured in the presence of 3 mM ATP for 24 or 48 h, and the cell viability was assessed at 24, 48, and 72 h by the exclusion of propidium iodide. Additionally, the number of the apoptotic cells was evaluated by flow cytometry analysis using fluorescein isothiocyanate-conjugated anti-annexin V antibody staining. As shown in Fig. 10 (A and B) , ATP had no influence on cell survival and the number of apoptotic cells. About 96% of the cells remained alive after 24, 48, and 72 h. Next, we evaluated the proliferation activity of Jurkat cells in response to ATP. As Fig. 10C , ATP was able to stimulate the proliferation of Jurkat cells in a dose-dependent manner, and the ATP antagonist, oATP, was able to block the observed proliferation response. This effect, however, was detectable not only in Jurkat cells but also, although to a slightly lesser extent, in p56 lck -deficient JCaM1 cells, which do not exhibit the characteristic phosphorylation pattern in response to extracellular ATP, indicating the proliferation of the cells in response to the ATP treatment as a more general phenomenon. This finding strongly invited further exploration of the biological relevance of the activation of p56 lck and MAP kinases in Jurkat cells. Therefore, as a next step, we tested by semi-quantitative RT-PCR a panel of various cytokines (e.g. IL-1␤, IL-2, IL-4, IL-7, IL-15, and IL-18) for possible changes in the level of transcription. Among these, only transcript codifying for IL-2 was clearly up-regulated (Fig. 10D, upper panel) . The MAP kinase pathway and activation of AP-1 transcription factor was reported by several groups to be required for IL-2 production (65, 66) . Unstimulated Jurkat and JCaM1 cells showed a weak transcription of IL-2 cytokine. However, stimulation with 3 mM ATP induced an increase in the amount of IL-2 transcript in Jurkat cells after only 3 h of ATP action, reaching its peak within 24 h of stimulation, whereas in JCaM1 cells IL-2 transcription remained at the same level throughout the time course of the experiment. Taken together, these results indicate that extracellular ATP has ability to induce proliferation of both Jurkat and JCaM1 cells and, presumably through the activation of p56 lck , MAP kinases and AP-1, to selectively upregulate IL-2 at transcriptional level in Jurkat cells alone.
DISCUSSION
Despite the obvious significance and broad distribution of cell surface receptors for extracellular nucleotides in many cellular systems, including the immune system, intracellular signaling pathways induced by extracellular ATP in lymphocytes are not understood well. This study provides evidence that extracellular ATP is able to induce activation of p56 lck and MAP kinases in Jurkat cells, followed by up-regulation of AP-1 and down-regulation of NF-B transcription factors. By using p56
lck -deficient cells, we demonstrate that p56 lck is required for the ATP-mediated downstream signaling, whereas the transfection with p56
lck gene reconstituted the ATP-induced cellular responses. To our knowledge, this is the first report to indicate that p56 lck kinase is required for ATP-mediated activation of AP-1, ERK and JNK, stimulation of IL-2, and down-regulation of NF-B in Jurkat cells.
The ability of Jurkat cells to proliferate in response to extracellular ATP, as shown by increased [ 3 H]thymidine incorporation, confirms the existence of functional purinoreceptors on the cell surface. Stimulation of DNA synthesis by extracellular nucleotides in a similar cell model was already documented (67) . The apparent lack of a P2X7-dependent cell death response in this T cell line is intriguing and deserves further exploration in follow-up experiments. Interestingly, transfection of P2X7 DNA into lymphoid cells lacking endogenous P2X7 receptors, K562 and LG14, was able to enhance cell proliferation in the absence of exogenous growth factors (31) . Furthermore, tumor transformation may lead to an increase in expression of the P2X7 receptor as well as to the release of a considerably higher amount of extracellular ATP (68) . The possible increase in proliferation rate, which expression of the P2X7 receptor appears to bestow upon the cells, may serve as a factor that confers a selective advantage and enhances their survival. In our experiments, however, both Jurkat and JCaM1 cells were able to proliferate after ATP stimulation. Therefore, we made an attempt to identify the biological significance of the observed signaling pathway in Jurkat cells more precisely. Reportedly, ATP stimulation may trigger a number of biologically relevant processes, such as cytokine production, cell proliferation, or apoptosis (26, 29 -34) . Semi-quantitative RT-PCR showed that the up-regulation of IL-2 on a transcriptional level was already detectable after first 3 h of ATP treatment, continuing to increase with the time course and reaching its peak after 24 h of stimulation. In striking contrast, JCaM1 cells exhibited no changes in the expression pattern of IL-2. Based on these findings, one might conclude that the up-regulated IL-2 transcription in Jurkat cells but not JCaM1 cells results as a direct consequence of the activation of the p56 lck , MAP kinases and AP-1, thus indicating the biological significance of the particular signaling pathway involved.
The nucleotide and pharmacological selectivity data strongly suggest that the ATP-induced downstream intracellular signaling events are results of activation of the P2X7 receptor. The involvement of P1 receptors was ruled out on the basis of the absence of an effect of adenosine, which can act as agonist at these receptors. Further, only millimolar concentrations of extracellular ATP had the capacity to induce the activation of signaling molecules, whereas ADP, AMP, UTP, and GTP were not able to trigger such changes in the phosphorylation pattern (data not shown). Next, the fact that the P2X7 receptor has the capacity to trigger a long lasting transmembrane Ca 2ϩ influx complies with our observation that ATP-induced intracellular signaling events in Jurkat cells were wholly dependent on cytoplasmic influx of extracellular Ca 2ϩ ions, as shown by the ability of EGTA, a chelator of divalent cations, to inhibit the protein phosphorylation via depletion of Ca 2ϩ ions in the culture medium prior to ATP treatment. The presence of mRNA for the P2X1, the P2X4, and, particularly, the P2X7 receptors was reported to be prominent in many immune cells (7, 20, 21 ). Thus, we tested by RT-PCR the expression of messages corresponding to the mammalian metabotropic P2Y receptors and to the ionotropic P2X receptors, with a particular interest to expression of the P2X7 receptor. RT-PCR confirmed the presence of mRNA for the P2X7, P2X1, and P2X5 receptors in Jurkat and JCaM1 cells but failed to detect messages corresponding to the other receptors of P2X family (P2X2-4 and P2X6) as well as to the P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 receptors. The expression of the P2X7 protein in the cells was also confirmed by Western blotting. As a next step, we evaluated the pharmacological selectivity characteristics to resolve the P2X receptor subtype underlying the intracellular consequences of the ATP action. First, oATP has been extensively utilized as an effective ATP antagonist, which covalently binds to and inhibits the P2X7 receptor (46) , although recent data indicate that this agent may not differentiate between multiple P2X receptor targets (26) . Therefore, we also used KN-62, an isoquinoline derivative and a CaM kinase inhibitor, which exhibits a strong species-dependent sensitivity for human P2X7 and is widely used as a most potent and selective antagonist of the P2X7 receptor (45) . The action of KN-62 upon the P2X7 does not involve its inhibitory properties on calmodulin kinase in short term studies; however, prolonged exposures to KN-62 require cautious interpretation, because they may also result in the inhibition of the CaM kinase II and are thus unsuited for long term studies on cell proliferation. Then, we used a well known agonist of the P2X7 receptor, Bz-ATP, which is believed to be more potent than ATP and can mimic its action at lower concentrations (below 1 mM) (7) . Pretreatment of the cells with oATP, KN-62, or suramin abrogated ATP-induced phosphorylation of p56 lck and MAP kinases, whereas treatment with Bz-ATP mimicked ATP effects, resulting in the similar phosphorylation pattern. The ability of Bz-ATP to induce Ca 2ϩ influx in the Jurkat cell line used in this study appears to contradict a recent report of Vigne et al. (69) , where Bz-ATP (up to 100 M) had no effect by itself to increase Ca 2ϩ in Jurkat cells and served as an antagonist of human and rat P2Y1 receptors. It should, however, be mentioned that expression of the purinoreceptors may vary considerably among different clonal variants of the same cell line maintained under different culture conditions, thus favoring different selection pressures on the cells that may account for the loss of the original morphological phenotype because of phenotypic instability, as was already shown for PC12 cells (54) . Therefore, the diverse pattern of purinoreceptor sensitivity among cell line batches utilized in different laboratories might contribute to a distinct pattern of response to extracellular nucleotides (7) . The requirement of ATP in a millimolar range and the ability of submillimolar amounts of Bz-ATP to mimic its effects taken together with inhibitory properties of KN-62 and oATP are typical for the pharmacological profile of the P2X7 receptor, strongly suggesting a role for it as the sole mediator of the following signaling events in Jurkat cells. p56 lck kinase activity is essential for the initiation of downstream signaling pathways in T cells (51, 52 (38) . In addition, p56 lck kinase was recently shown to be required for the ceramide-induced and HIV-tat protein-induced activation of MEK and JNK, AP-1, and NF-B transcription factors in Jurkat cells (59, 70) . Importantly, calcium ionophores can trigger activation of p56 lck and ERK1/2 in Jurkat cells via calmodulin and a CaM kinase-dependent mechanism (44) . Furthermore, one signaling pathway that is required for IL-2 production is MAP kinase cascade through the action of the transcription factor AP-1 (65, 66) . The involvement of p56 lck in TCR signaling appears to be complex, indicating its selective requirement for the activation of downstream signaling pathways, such as MAP kinase pathway, despite the activation of ZAP-70 and phosphatidylinositol in a p56
lck -deficient JCaM1 cell line (38) . To examine the role of p56 lck in the ATP-induced downstream signaling more precisely, we also employed JCaM1 cells, a genetic variant of Jurkat cell line, deficient in p56 lck protein expression because of the deletion of exon 7 (36, 38) . ATP failed to stimulate activation of MAP kinases ERK1/2 and JNK1/2 and to induce an increase in the DNA binding activity of AP-1 in these cells, whereas transfection with the gene coding for p56
lck reconstituted the ATP-induced cellular responses. Thus, the selective disruption of the MAP kinase pathway in p56
lck -deficient cells demonstrates that there exists an additional requirement of this kinase for the activation of downstream signaling events and suggests an upstream location for p56 lck in the ATP signaling pathway. The activation of p56 lck kinase upon the ATP action does not seem to depend on or be preceded by the activation of other mediator of Ca 2ϩ signaling, Pyk2 (data not shown), nor does it require the involvement of calmodulin and CaM kinase, as shown by the inability of both calmidazolium, a calmodulin antagonist, and CaM kinase inhibitor KN-93 to abrogate the activation of p56 lck and ERK, although CaM kinase appears to participate, at least partially, in the observed activation of ERK. Furthermore, a specific inhibitor of MEK, PD098059, had capacity to abrogate phosphorylation of ERK in response to ATP, while not affecting activation of p56 lck kinase. The fact that extracellular ATP, acting over the P2X7 receptor, is able to stimulate p56 lck -dependent phosphorylation and activation of ERK and JNK, but not p38 kinase, demonstrates a novel pathway by which this agent can modulate the intracellular responses on various levels. The precise molecular mechanisms underlying the ability of ATP to trigger the activation of p56 lck and MAP kinases through the P2X7 receptor remain unknown. Although an increase in the intracellular level of Ca 2ϩ appears to be critical for the subsequent signaling events, the inability of the P2X7 to mediate activation of the MAP kinases in the absence of p56 lck in JCaM1 cells unambiguously indicates that a simple rise in the level of intracellular Ca 2ϩ ions is not enough. Although MEK seems to contribute to the observed activation of ERK, it is not clear yet how p56 lck kinase might couple to MEK and, in general, mediate its effects on activation of the MAP kinases and AP-1 in response to ATP, and future studies are required to address this question in more detail.
A plethora of physiological and pathological stimuli is able to induce and activate a group of DNA-binding proteins that form the AP-1 complex, which binds to AP-1 regulatory elements in the promoter and enhancer regions of numerous mammalian genes, including IL-2 (65, 66) . In unstimulated T cells, AP-1 expression is low or undetectable, with a rapid induction of AP-1 activity after T cell stimulation, such as TCR/CD3 binding and action of cytokines or hormones (71) (72) (73) . The ATP-mediated induction of c-Jun and c-Fos expression, followed by the up-regulation of DNA binding activity of AP-1 may mirror, at least in part, the initial steps in T cell activation, which are usually orchestrated through the recruitment of several transcriptional factors, such as AP-1, nuclear factor of activated T cells (NFAT), and NF-B (73). AP-1 probe and nuclear proteins were able to form complexes within 30 min from the action of ATP and were still present after 3 h. The supershifting experiments showed that c-Jun and c-Fos proteins are the constituents of the activated AP-1 transcription complex. As already mentioned above, the MAP kinase cascade is crucial for AP-1 induction and IL-2 gene expression in T cells (65, 66) , because it regulates tightly at the transcriptional and post-translational levels of AP-1 activity, increasing its stability and binding activity through phosphorylation (73, 74) .
Another important inducible transcription factor that plays a pivotal role in many cellular responses to environmental changes is NF-B. The factor is ubiquitously found as an inactive complex in the cytoplasm bound to its inhibitory subunit IB and plays an important role in the cell growth, differentiation, development, apoptosis, inflammation, and immune responses (75, 76) . NF-B is also able to function in concert with other transcription factors, such as AP-1 (57) . In contrast to the activation of AP-1, we detected a simultaneous, although slightly accelerated decrease in DNA binding activity of NF-B p65 (Rel A) and p50 proteins, as evidenced by the supershift experiments, within the first hour of the ATP action. The level of NF-B proteins slowly returned nearly to basal after 3 h. It should be mentioned that we did not observe an increase in the expression of IB␣ upon ATP treatment. 2 The biological relevance of such opposite responses as the activation of AP-1 and down-regulation of NF-B is not clear, and future experiments must be aimed to shed light on this issue.
Taken together, our results demonstrate that ATP induces Ca 2ϩ -dependent activation of p56 lck tyrosine kinase, which is prerequisite for the activation of ERK and JNK MAP kinases, up-regulates transcriptional factor AP-1, and stimulates IL-2 transcription, while down-regulating DNA binding activity of NF-B. Thus, the intracellular events occurring in Jurkat cells in response to extracellular ATP may represent a heretofore unappreciated mechanism of its ability to modulate cellular processes within the immune system. 
